The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Prostek, Adam ^a   Gajewska, Małgorzata ^a   Kamola, Dariusz ^a   Bałasińska, Bozena ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Adipocytes; Ageing; DHA; EPA; Inflammation; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALBUMIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LEPTIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL AGING; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ELISA KIT; EMBRYO; FIBROBLAST CULTURE; HORMONE RELEASE; HORMONE SYNTHESIS; INFLAMMATION; LIPID STORAGE; MOUSE; MOUSE EMBRYO; NONHUMAN; OIL RED O STAINING; STAINING; 3T3 CELL LINE; AGE; ANTIINFLAMMATORY ACTIVITY; DEVELOPMENTAL STAGE; PROTEIN SYNTHESIS;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CELL AGING; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; INFLAMMATION MEDIATORS; LEPTIN; LIPOLYSIS; MICE;

EID: 84893367199     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-3     Document Type: Article

References (38)

1. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Bucher HC, Hengstler P, Schindler C, Meier G, Am J Med 2002 112 298 304 10.1016/S0002-9343(01)01114-7 11893369 (Pubitemid 34219443)
2. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chapkin RS, Seo J, McMurray DN, Lupton JR, Chem Phys Lipids 2008 153 14 23 10.1016/j. chemphyslip.2008.02.011 18346463
3. PUFA for prevention and treatment of dementia? Carrié I, Abellan Van Kan G, Rolland Y, Gillette-Guyonnet S, Vellas B, Curr Pharm Des 2009 15 4173 4185 10.2174/138161209789909764 20041819
4. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Oliver E, McGillicuddy F, Phillips C, Toomey S, Roche HM, Proc Nutr Soc 2010 69 232 243 10.1017/S0029665110000042 20158940
5. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Calder PC, Am J Clin Nutr 2006 83 Suppl 6 1505 1519
6. Resolvins and protectins in inflammation resolution. Serhan CN, Petasis NA, Chem Rev 2011 111 5922 5943 10.1021/cr100396c 21766791
7. Lipoxin A4 attenuates adipose inflammation. Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C, FASEB J 2012 26 4287 4294 10.1096/fj.12-208249 22700871
8. Pro-inflammatory cytokines and adipose tissue. Coppack SW, Proc Nutr Soc 2001 60 349 356 10.1079/PNS2001110 11681809 (Pubitemid 32772450)
9. Obesity and the role of adipose tissue in inflammation and metabolism. Greenberg AS, Obin MS, Am J Clin Nutr 2006 83 461 465
10. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Fain JN, Vitam Horm 2006 74 443 477 17027526
11. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Trayhurn P, Wood IS, Br J Nutr 2004 92 347 355 10.1079/BJN20041213 15469638 (Pubitemid 40277057)
12. Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. Gregor MF, Hotamisligil GS, J Lipid Res 2007 48 1905 1914 10.1194/jlr.R700007-JLR200 17699733 (Pubitemid 47360610)
13. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-A review. Buckley JD, Howe PR, Nutrients 2010 12 1212 1230
14. Is omega-3 key to unlocking inflammation in obesity? White PJ, Marette A, Diabetologia 2006 49 1999 2001 10.1007/s00125-006-0346-9 16826406 (Pubitemid 44168464)
15. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Flachs P, Rossmeisl M, Bryhn M, Kopecky J, Clin Sci (Lond) 2009 116 1 16 10.1042/CS20070456 19037880
16. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. Escrivá F, Gavete ML, Fermín Y, Pérez C, Gallardo N, Alvarez C, Andrés A, Ros M, Carrascosa JM, J Endocrinol 2007 194 131 141 10.1677/joe.1.07043 17592027 (Pubitemid 47162893)
17. Adipogenesis and aging: does aging make fat go MAD? Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I, Exp Gerontol 2002 37 757 767 10.1016/S0531-5565(02)00014-1 12175476 (Pubitemid 34518494)
18. Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. Yu YH, Zhu H, Am J Physiol Endocrinol Metab 2004 286 402 410
19. In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation. Zoico E, Di Francesco V, Olioso D, Fratta Pasini AM, Sepe A, Bosello O, Cinti S, Cominacini L, Zamboni M, Biogerontology 2010 11 111 122 10.1007/s10522-009-9236-0 19526322
20. Relationship between adipocyte size and adipokine expression and secretion. Skurk T, Alberti-Huber C, Herder C, Hauner H, J Clin Endocrinol Metab 2007 92 1023 1033 10.1210/jc.2006-1055 17164304 (Pubitemid 46465679)
21. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. Kim HK, Della-Fera M, Lin J, Baile CA, J Nutr 2006 136 2965 2969 17116704 (Pubitemid 44878557)
22. Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes. Lee MS, Kwun IS, Kim Y, Genes Nutr. 2008 2 327 330 10.1007/s12263-007-0068-8 18850226 (Pubitemid 351447707)
23. Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes. Manickam E, Sinclair AJ, Cameron-Smith D, Lipids Health Dis 2010 9 57 10.1186/1476-511X-9-57 20525346
24. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T, Nat Med 2001 7 941 946 10.1038/90984 11479627 (Pubitemid 32756432)
25. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE, Diabetes 2003 52 268 276 10.2337/diabetes.52.2.268 12540596 (Pubitemid 36173178)
26. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N, J Nutr 2010 140 1915 1922 10.3945/jn.110.125732 20861209
27. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6 J mice adipose tissue. Bueno AA, Oyama LM, de Oliveira C, Pisani LP, Ribeiro EB, Silveira VL, Oller do Nascimento CM, Pflugers Arch 2008 455 701 709 17717684 (Pubitemid 350160482)
28. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARγ mRNA, in 3T3-L1 adipocytes. Oster RT, Tishinsky JM, Yuan Z, Robinson LE, Appl Physiol Nutr Metab 2010 35 783 789 10.1139/H10-076 21164549
29. Regulation of adipokine secretion by n-3 fatty acids. Moreno-Aliaga MJ, Lorente-Cebrián S, Martínez JA, Proc Nutr Soc 2010 69 324 332 10.1017/S0029665110001801 20540825
30. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. Pérez-Matute P, Marti A, Martínez JA, Fernández-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ, Am J Physiol Regul Integr Comp Physiol 2005 288 1682 1688 10.1152/ajpregu.00727.2004 (Pubitemid 40720718)
31. Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro. Murata M, Kaji H, Takahashi Y, Iida K, Mizuno I, Okimura Y, Abe H, Chihara K, Biochem Biophys Res Commun 2000 270 343 348 10.1006/bbrc.2000.2424 10753628 (Pubitemid 30446839)
32. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA, J Lipid Res 2001 42 743 750 11352981 (Pubitemid 32509598)
33. The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression. Ukropec J, Reseland JE, Gasperikova D, Demcakova E, Madsen L, Berge RK, Rustan AC, Klimes I, Drevon CA, Sebökova E, Lipids 2003 38 1023 1029 10.1007/s11745-006-1156-z 14669966 (Pubitemid 37444625)
34. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA, Pinkney J, J Clin Endocrinol Metab 2001 86 5864 5869 11739453 (Pubitemid 33152636)
35. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW, Endocrinology 2004 145 2273 2282 10.1210/en.2003-1336 14726444 (Pubitemid 38535056)
36. Interleukin-6 induces cellular insulin resistance in hepatocytes. Senn JJ, Klover PJ, Nowak IA, Mooney RA, Diabetes 2002 51 3391 3399 10.2337/diabetes.51.12.3391 12453891 (Pubitemid 35403441)
37. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA, J Biol Chem 2003 278 13740 13746 10.1074/jbc.M210689200 12560330 (Pubitemid 36799910)
38. n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-κB-dependent mechanisms. Siriwardhana N, Kalupahana NS, Fletcher S, Xin W, Claycombe KJ, Quignard-Boulange A, Zhao L, Saxton AM, Moustaid-Moussa N, J Nutr Biochem 2012 23 1661 1667 10.1016/j.jnutbio.2011.11.009 22475809